Bristol-Myers Squibb Company (NYSE:
BMY) and AstraZeneca (NYSE:
AZN) will host a conference call at 9 a.m. (ET) on Tuesday, September 9
to review data presented at the 44th annual
meeting of the European Association for the Study of Diabetes (EASD),
being held from September 7-11 in Rome. Company executives will provide
an overview of data presented at the meeting on the diabetes portfolio
and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at http://www.bms.com/ir
or by dialing 913-312-0405, confirmation code: 2419787. A replay of the
call will be available beginning at 12:00p.m. (ET) on September 9
through midnight (ET) on September 21. The replay can be accessed at http://www.bms.com/ir
or by dialing 402-280-9013, confirmation code: 2419787.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to extend and enhance human life.
Bristol-Myers Squibb
Media:
David Rosen,
609-252-5675
david.rosen@bms.com
Investors:
John
Elicker, 212-546-3775
john.elicker@bms.com
or
AstraZeneca
Media:
Jim
Minnick, 302-866-5135
jim.minnick@astrazeneca.com
Investors:
Mina
Blair, 44-207-304-5084
mina.blair@astrazeneca.com
